KR20200145340A - Composition for skin whitening comprising ulmus pumila extract - Google Patents
Composition for skin whitening comprising ulmus pumila extract Download PDFInfo
- Publication number
- KR20200145340A KR20200145340A KR1020190074209A KR20190074209A KR20200145340A KR 20200145340 A KR20200145340 A KR 20200145340A KR 1020190074209 A KR1020190074209 A KR 1020190074209A KR 20190074209 A KR20190074209 A KR 20190074209A KR 20200145340 A KR20200145340 A KR 20200145340A
- Authority
- KR
- South Korea
- Prior art keywords
- bisul
- extract
- skin whitening
- tree
- cosmetic composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 239000000284 extract Substances 0.000 title claims abstract description 27
- 230000002087 whitening effect Effects 0.000 title claims abstract description 17
- 244000058281 Ulmus pumila Species 0.000 title abstract description 5
- 235000001547 Ulmus pumila Nutrition 0.000 title abstract description 5
- 230000000694 effects Effects 0.000 claims abstract description 28
- 102000003425 Tyrosinase Human genes 0.000 claims abstract description 17
- 108060008724 Tyrosinase Proteins 0.000 claims abstract description 17
- 239000002537 cosmetic Substances 0.000 claims abstract description 16
- 239000004480 active ingredient Substances 0.000 claims abstract description 14
- 235000013402 health food Nutrition 0.000 claims abstract description 8
- 102000029816 Collagenase Human genes 0.000 claims description 12
- 108060005980 Collagenase Proteins 0.000 claims description 12
- 102000016387 Pancreatic elastase Human genes 0.000 claims description 12
- 108010067372 Pancreatic elastase Proteins 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- 229960002424 collagenase Drugs 0.000 claims description 11
- 239000006210 lotion Substances 0.000 claims description 8
- 239000006071 cream Substances 0.000 claims description 7
- 238000009472 formulation Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 229910052797 bismuth Inorganic materials 0.000 claims description 5
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 claims description 5
- 235000016709 nutrition Nutrition 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 239000012046 mixed solvent Substances 0.000 claims description 2
- 235000015097 nutrients Nutrition 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 abstract description 24
- 230000019612 pigmentation Effects 0.000 abstract description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 32
- 239000000401 methanolic extract Substances 0.000 description 28
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 18
- 210000003491 skin Anatomy 0.000 description 17
- 235000010323 ascorbic acid Nutrition 0.000 description 16
- 229960005070 ascorbic acid Drugs 0.000 description 16
- 239000011668 ascorbic acid Substances 0.000 description 16
- 239000013641 positive control Substances 0.000 description 10
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 8
- 102000008186 Collagen Human genes 0.000 description 7
- 108010035532 Collagen Proteins 0.000 description 7
- 229920001436 collagen Polymers 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 208000012641 Pigmentation disease Diseases 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 238000012790 confirmation Methods 0.000 description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 6
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 5
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 5
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 210000002744 extracellular matrix Anatomy 0.000 description 5
- 229930003935 flavonoid Natural products 0.000 description 5
- 150000002215 flavonoids Chemical class 0.000 description 5
- 235000017173 flavonoids Nutrition 0.000 description 5
- 150000008442 polyphenolic compounds Chemical class 0.000 description 5
- 235000013824 polyphenols Nutrition 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- -1 tracant Substances 0.000 description 5
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 239000001263 FEMA 3042 Substances 0.000 description 4
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 229960000271 arbutin Drugs 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 231100000673 dose–response relationship Toxicity 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 229920002258 tannic acid Polymers 0.000 description 4
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 4
- 229940033123 tannic acid Drugs 0.000 description 4
- 235000015523 tannic acid Nutrition 0.000 description 4
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 3
- 102000016942 Elastin Human genes 0.000 description 3
- 108010014258 Elastin Proteins 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229920002549 elastin Polymers 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000036074 healthy skin Effects 0.000 description 3
- 239000005445 natural material Substances 0.000 description 3
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 3
- 239000003642 reactive oxygen metabolite Substances 0.000 description 3
- 235000005493 rutin Nutrition 0.000 description 3
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 3
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 3
- 229960004555 rutoside Drugs 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 102000012422 Collagen Type I Human genes 0.000 description 2
- 108010022452 Collagen Type I Proteins 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 2
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000010200 folin Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000003061 melanogenesis Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- WLJYNHBZKOQNNI-UHFFFAOYSA-N 5-(diaminomethylideneamino)-2-[[1-[2-[[4-methyl-2-[[1-[(4-phenyldiazenylphenyl)methoxycarbonyl]pyrrolidine-2-carbonyl]amino]pentanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]pentanoic acid Chemical compound C1CCC(C(=O)NC(CCCN=C(N)N)C(O)=O)N1C(=O)CNC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)OCC(C=C1)=CC=C1N=NC1=CC=CC=C1 WLJYNHBZKOQNNI-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000001187 Collagen Type III Human genes 0.000 description 1
- 108010069502 Collagen Type III Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 241000193159 Hathewaya histolytica Species 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 108010067035 Pancrelipase Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 230000011382 collagen catabolic process Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 102000034240 fibrous proteins Human genes 0.000 description 1
- 108091005899 fibrous proteins Proteins 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Abstract
Description
본 발명은 비술나무 추출물을 유효성분으로 함유하는 피부미백용 조성물에 관한 것이다.The present invention relates to a composition for skin whitening containing a bisul tree extract as an active ingredient.
최근 건강한 피부에 대한 관심이 높아지면서 천연물소재 화장품에 대한 연구가 활발히 진행되고 있고, 특히 색소침착형의 기미(melasma)나 주근깨(freckle)와 같은 피부질환이나 염증성 여드름과 같은 각종 피부 트러블에 대한 예방 및 치료에 대한 관심이 높아지고 있다.Recently, as interest in healthy skin has increased, research on cosmetics made of natural substances is being actively conducted.In particular, prevention of various skin problems such as inflammatory acne or skin diseases such as pigmented melanoma and freckle And interest in treatment is increasing.
피부는 표피(epidermis), 진피(dermis), 그리고 피하층(hypodermis)으로 구성되며, 진피에서는 교원질(collagen)과 탄력소(elastin) 등으로 구성된 세포외기질(extracellular matrix, ECM)이 피부 섬유아세포(fibroblast)에 의해 합성되고 유지된다. The skin consists of the epidermis, the dermis, and the hypodermis, and in the dermis, the extracellular matrix (ECM) consisting of collagen and elastin, etc. fibroblast).
콜라겐(Collagen)은 세포외기질(extracellular matrix, ECM)과 결합조직의 주요 불용성 섬유질단백질이며 그 주요기능은 피부탄력을 유지하는 것이다. 콜라겐은 16종류가 존재하며 인체의 collagen 중 약80∼90%가 I, II, III 타입으로 구성된다.Ⅰ형 콜라겐(type I collagen)은 정상적인 피부에서 collagen의 약 75-80%를 차지하고, 뼈 유기 질량의 90%이상을 형성하며 인대, 각막 및 많은 간질 결합조직의 주요 collagen이며, 피부의 주요 ECM성분이며 구조적 완전성을 책임진다. Collagen is a major insoluble fibrous protein in the extracellular matrix (ECM) and connective tissue, and its main function is to maintain skin elasticity. There are 16 types of collagen, and about 80-90% of the collagen in the human body is composed of types I, II, and III. Type I collagen accounts for about 75-80% of collagen in normal skin, and bone It forms more than 90% of the organic mass, is a major collagen in ligaments, corneas and many interstitial connective tissues, is a major ECM component of the skin, and is responsible for structural integrity.
Ⅰ형 콜라겐이 대부분이고 III 형 콜라겐이 소량 포함되어 있으며 피부에 탄력을 주는 엘라스틴 (elastin)이 3∼4%정도 함유되어 있다. 콜라게나아제 (Collagnases)의 대부분은 기질금속단백질분해효소(matrix metalloproteinases, MMPs)군에 속하며 펩티드결합을 끊음으로써 콜라겐 분해를 일으킨다. 이러한 피부 노화는 멜라닌 (melanin) 축적뿐만 아니라 유해 활성산소종(reactive oxygen species, ROS)의 축적에 의해서도 야기된다. 체내 항산화 효소계에 의해 제거되지 못한 유해 활성산소종은 세포, 지질, 단백질, DNA 등에 손상을 주어 세포 및 진피 층의 주요 구성성분을 파괴하여 주름, 탄력저하 등의 원인이 된다.Most of the type Ⅰ collagen, type III collagen is contained in a small amount, and contains 3-4% of elastin, which gives elasticity to the skin. Most of the collagenases belong to the matrix metalloproteinases (MMPs) group and cause collagen degradation by breaking peptide bonds. Such skin aging is caused not only by accumulation of melanin but also by accumulation of reactive oxygen species (ROS). Harmful reactive oxygen species that cannot be removed by the body's antioxidant enzyme system damage cells, lipids, proteins, DNA, etc., destroying major components of cells and dermal layers, causing wrinkles and loss of elasticity.
피부의 표피에 존재하는 멜라닌(melanin)은 피부색을 결정하는 중요한 요인 중 하나로 멜라닌 색소의 양과 분포에 의해 외관상의 피부색이 결정된다. 자외선이 조사되면 피부를 보호하기 위해 멜라닌세포(melanocyte)에서 멜라닌 생성반응과정(melanogenesis)을 통해 멜라닌이 생성되고, 이 생성된 멜라닌에 의해 피부색이 검게 변화하여 색소 침착이 일어나게 된다.Melanin present in the epidermis of the skin is one of the important factors determining skin color, and the apparent skin color is determined by the amount and distribution of melanin pigments. When ultraviolet rays are irradiated, melanin is produced through melanogenesis in melanocytes to protect the skin, and the skin color is changed to black by the generated melanin, resulting in pigmentation.
티로시나아제 (Tyrosinase)는 멜라닌 생성 첫 단계를 일으키는 효소로, 티로신(tyrosine)이 도파(3,4-dihydroxyphenilalanine, DOPA)를 거쳐 도파퀴논(DOPA quinone)으로 전환되고, 도파퀴논으로부터 자동 산화 반응과 효소 반응으로 도파크롬(DOPA chrome)으을 거쳐 흑갈색의 공중합체인 멜라닌이 생성되게 된다. Tyrosinase is an enzyme that causes the first stage of melanogenesis, and tyrosine is converted to dopaquinone via dopa (3,4-dihydroxyphenilalanine (DOPA)). Through an enzymatic reaction, melanin, a dark brown copolymer, is produced through DOPA chrome.
현재 미백제의 개발에 있어서, 생성된 멜라닌색소를 환원시켜 탈색하는 방법과 멜라닌색소를 형성하는 효소인 티로시나아제의 활성을 억제하는 방법이 알려져 있으며, 자외선, 호르몬, 염증 등의 원인에 의해 과도하게 생성된 멜라닌은 피부에 색소를 침착시켜 기미, 주근깨를 형성하며, 피부암의 원인이 되기도 한다. Currently, in the development of whitening agents, a method of decolorizing by reducing the produced melanin pigment and a method of inhibiting the activity of tyrosinase, an enzyme that forms melanin pigment, are known. The produced melanin deposits pigmentation on the skin to form spots and freckles, and may also cause skin cancer.
이에 따라 피부 노화 및 색소 침착을 억제하는 등 건강한 피부 유지를 위한 천연소재의 개발이 절실히 요구된다.Accordingly, there is an urgent need to develop natural materials for maintaining healthy skin, such as inhibiting skin aging and pigmentation.
본 발명은 피부색소 침착을 억제하여 건강한 피부 유지하기 위한 천연소재로 비술나무 추출물을 유효성분으로 함유하는 조성물을 제공하고자 한다. An object of the present invention is to provide a composition containing a bisul tree extract as an active ingredient as a natural material for maintaining healthy skin by inhibiting skin pigmentation.
본 발명은 비술나무 추출물을 유효성분으로 함유하는 피부미백용 화장료 조성물을 제공한다.The present invention provides a cosmetic composition for skin whitening containing a bisul tree extract as an active ingredient.
또한, 본 발명은 비술나무 추출물을 유효성분으로 함유하는 피부미백용 건강식품을 제공한다.In addition, the present invention provides a health food for skin whitening containing a bisul tree extract as an active ingredient.
본원발명에 따르면, 비술나무 추출물이 색소 침착을 유도하는 티로시나아제 활성을 억제하는 효과를 나타내는 것으로 확인됨에 따라, 상기 비술나무 추출물을 유효성분으로 함유하는 조성물을 피부미백용 화장료 조성물 또는 건강식품으로 제공할 수 있다.According to the present invention, as it was confirmed that the bisul tree extract exhibits an effect of inhibiting the tyrosinase activity that induces pigmentation, a composition containing the bisul tree extract as an active ingredient is used as a cosmetic composition or health food for skin whitening. Can provide.
도 1은 비술나무 메탄올추출물 (UPME) 전체 폴리페놀 및 플라보노이드 함량을 확인한 결과로, 3번 반복 실험 후 값을 평균 ± SD로 나타내었으며, 전체 폴리페놀 및 플라보노이드 함량의 정량을 위해 각각 탄닌산 및 루틴을 이용하여 검량곡선을 나타내었다.
도 2는 비술나무 메탄올추출물 (UPME)의 전자공여능을 확인한 결과로, 3번 반복 실험 후 값을 평균 ± SD로 나타내었으며, AA는 아스코르빅산이다.
도 3은 비술나무 메탄올추출물 (UPME)의 콜라게나아제 활성 억제 효과를 확인한 결과로, 3번 반복 실험 후 값을 평균 ± SD로 나타내었으며, AA는 아스코르빅산이다.
도 4는 비술나무 메탄올추출물 (UPME)의 엘라스타아제 활성 억제 효과를 확인한 결과로, 3번 반복 실험 후 값을 평균 ± SD로 나타내었으며, AA는 아스코르빅산이다.
도 5는 비술나무 메탄올추출물 (UPME)의 버섯 티로시나아제 활성 억제 효과를 확인한 결과로, 3번 반복 실험 후 값을 평균 ± SD로 나타내었다.1 is a result of confirming the total polyphenol and flavonoid content of the bisul tree methanol extract (UPME), and the value after 3 repeated experiments was shown as mean ± SD, and tannic acid and rutin were respectively used for quantification of the total polyphenol and flavonoid content. The calibration curve was shown using.
Figure 2 is a result of confirming the electron donating ability of the methanol extract (UPME) of bisulnamu, the value after repeated experiments 3 times was shown as mean ± SD, AA is ascorbic acid.
Figure 3 is a result of confirming the inhibitory effect of the collagenase activity of the methanol extract (UPME) bisulnamu, and the value after repeated experiments 3 times was shown as mean ± SD, AA is ascorbic acid.
Figure 4 is a result of confirming the inhibitory effect of the elastase activity of the methanol extract (UPME) of Bisul tree, the value after repeated experiments 3 times was shown as mean ± SD, AA is ascorbic acid.
5 is a result of confirming the mushroom tyrosinase activity inhibitory effect of the bisulnamu methanol extract (UPME), the values after repeated experiments 3 times are shown as mean ± SD.
이하, 본 발명을 보다 상세하게 설명한다. Hereinafter, the present invention will be described in more detail.
본 발명은 비술나무 추출물을 유효성분으로 함유하는 피부미백용 화장료 조성물을 제공할 수 있다.The present invention can provide a cosmetic composition for skin whitening containing a bisul tree extract as an active ingredient.
상기 비술나무 추출물은 물, C1 내지 C4의 알콜, 또는 이들의 혼합용매로 추출되는 것일 수 있다. 보다 바람직하게는 메탄올 추출물일 수 있으나, 이에 한정되는 것은 아니다.The bisul tree extract may be extracted with water, C1 to C4 alcohol, or a mixed solvent thereof. More preferably, it may be a methanol extract, but is not limited thereto.
상기 비술나무 추출물은 티로시나아제, 콜라게나아제 또는 엘라스타아제의 활성을 억제하는 것일 수 있다.The bisul tree extract may be one that inhibits the activity of tyrosinase, collagenase, or elastase.
본 발명의 실시예에 따르면, 비술나무 추출물의 주름개선 효과를 확인하기 위해, 양성대조군인 아스코르빅산과 탄력 섬유인 콜라겐과 엘라스틴을 분해시켜 피부 주름생성을 유도하는 콜라게나아제 및 엘라스타아제에 처리하여 각각의 활성 저해 효과를 확인한 결과, 도 3과 같이 아스코르빅산와 비술나무 메탄올추출의 콜라게나아제 활성저해능은 1000 μg/mL에서 각각 71.7% 및 69.4%로 비술나무 메탄올추출물의 콜라게나아제 활성저해능이 양성대조군인 아스코르빅산과 유사한 수준으로 확인되었다. 또한, 도 4와 같이 아스코르빅산와 비술나무 메탄올추출의 엘라스타아제 활성저해능은 1000 μg/mL에서 각각 45.6% 및 61.2%로 나타남에 따라, 엘라스타아제 활성 억제효과는 비술나무 메탄올추출물이 양성대조군인 아스코르빅산 보다 우수한 것으로 확인되었다.According to an embodiment of the present invention, in order to confirm the anti-wrinkle effect of the extract of the bisul tree, collagenase and elastase that induce skin wrinkles by decomposing ascorbic acid as a positive control and collagen and elastin as elastic fibers are used. As a result of confirming each activity inhibitory effect by treatment, the collagenase activity inhibitory activity of the methanol extract of ascorbic acid and the bismuth tree was 71.7% and 69.4% respectively at 1000 μg/mL as shown in FIG. 3. The activity inhibitory activity was confirmed to be similar to that of the positive control, ascorbic acid. In addition, as shown in Fig. 4, ascorbic acid and bisulfuric acid methanol extract exhibited 45.6% and 61.2% of elastase activity inhibition at 1000 μg/mL, respectively, so that the inhibitory effect of elastase activity was positive for the bisulfuric acid methanol extract. It was found to be superior to the control ascorbic acid.
또한, 본 발명의 다른 실시예에 따르면, 비술나무 추출물의 미백효과를 확인하기 위해, 색소 침착을 유도하는 티로시나아제에 비술나무 메탄올 추출물을 처리하여 티로시나아제 활성 억제효과를 확인한 결과, 도 5와 같이 양성대조군인 알부틴과 비술나무 메탄올추출물의 티로시나아제 활성저해능은 1000 μg/mL 농도에서 각각 70.8% 및 65.9%로 나타남에 따라, 비술나무 메탄올추출물의 티로시나아제 활성저해능이 양성대조군인 알부틴과 유사한 수준으로 확인되었다.In addition, according to another embodiment of the present invention, in order to confirm the whitening effect of the bisul tree extract, as a result of confirming the tyrosinase activity inhibitory effect by treating the bisul tree methanol extract with tyrosinase that induces pigmentation, FIG. 5 As shown, the inhibitory activity of tyrosinase activity of the positive controls arbutin and the methanol extract of Bisulaceae was 70.8% and 65.9%, respectively, at a concentration of 1000 μg/mL. It was confirmed at a level similar to that of.
상기 결과로부터 비술나무 메탄올추출물은 피부미백용 기능성 천연소재로 활용가능성이 높은 것으로 확인되었다.From the above results, it was confirmed that the methanol extract of bisul tree has high potential for use as a functional natural material for skin whitening.
상기 화장료 조성물은 조성물 총 100 중량부에 대하여, 비술나무 추출물이 0.1 내지 90 중량부로 포함되는 것일 수 있다.The cosmetic composition may be contained in an amount of 0.1 to 90 parts by weight of a bisul tree extract based on a total of 100 parts by weight of the composition.
상기 화장료 조성물은 유연화장수, 영양화장수, 영양크림, 엣센스 또는 팩의 제형을 갖는 것일 수 있다.The cosmetic composition may have a formulation of a flexible lotion, a nutritional lotion, a nutritional cream, an essence, or a pack.
상기 화장료 조성물은 유효성분인 비술나무 추출물 외에 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제, 그리고 담체를 포함할 수 있다.The cosmetic composition may include a stabilizer, solubilizing agent, vitamins, pigments, and conventional adjuvants, such as a flavoring agent, and a carrier in addition to the extract of the bisul tree as an active ingredient.
상기 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 썬 크림, 유연 화장수, 수렴 화장수, 영양 화장수, 영양 크림, 마사지 크림, 에센스, 아이 크림, 팩, 스프레이 또는 파우더의 제형으로 제조될 수 있다.The cosmetic composition may be prepared in any formulation conventionally prepared in the art, for example, solution, suspension, emulsion, paste, gel, cream, lotion, powder, oil, powder foundation, emulsion foundation, It may be formulated as a wax foundation or spray, but is not limited thereto. More specifically, it may be prepared in the form of a sun cream, a flexible lotion, a converging lotion, a nutrition lotion, a nutrition cream, a massage cream, an essence, an eye cream, a pack, a spray, or a powder.
상기 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜,실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation is a paste, cream or gel, animal oil, vegetable oil, wax, paraffin, starch, tracant, cellulose derivatives, polyethylene glycol, silicon, bentonite, silica, talc, or zinc oxide may be used as a carrier component. .
상기 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation is a powder or spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component, and in particular, in the case of a spray, additional chlorofluorohydrocarbon, propane/butane Or a propellant such as dimethyl ether.
상기 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해 화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation is a solution or emulsion, a solvent, a solubilizing agent or an emulsifying agent is used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3 -Butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or fatty acid ester of sorbitan.
상기 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the above formulation is a suspension, a liquid diluent such as water, ethanol or propylene glycol as a carrier component, an ethoxylated isostearyl alcohol, a suspending agent such as polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystalline cellulose , Aluminum metahydroxide, bentonite, agar or tracant, and the like may be used.
본 발명은 비술나무 추출물을 유효성분으로 함유하는 피부미백용 건강식품을 제공할 수 있다.The present invention can provide a health food for skin whitening containing a bisul tree extract as an active ingredient.
상기 건강식품은 상기 비술나무 추출물 이외에 다른 식품 또는 식품 첨가물과 함께 사용되고, 통상적인 방법에 따라 적절하게 사용될 수 있다.유효성분의 혼합양은 그의 사용 목적 예를들어 예방, 건강 또는 치료적 처치에 따라 적합하게 결정될 수 있다.The health food is used together with other foods or food additives in addition to the bismuth extract, and may be appropriately used according to a conventional method. The mixed amount of the active ingredient is suitable for its purpose of use, such as prevention, health, or therapeutic treatment. Can be determined.
상기 건강식품에 함유된 화합물의 유효용량은 상기 치료제의 유효용량에 준해서 사용할 수 있으나, 건강 및 위생을 목적으로 하거나 또는 건강 조절을 목적으로 하는 장기간의 섭취의 경우에는 상기 범위 이하일 수 있으며, 유효성분은 안전성 면에서 아무런 문제가 없기 때문에 상기 범위 이상의 양으로도 사용될 수 있음은 확실하다.The effective dose of the compound contained in the health food may be used in accordance with the effective dose of the therapeutic agent, but in the case of long-term intake for the purpose of health and hygiene or health control, it may be less than the above range, and is effective. It is clear that the ingredient can be used in an amount beyond the above range because there is no problem in terms of safety.
상기 건강식품의 종류에는 특별한 제한이 없고, 예로는 육류, 소세지, 빵, 쵸코렛, 캔디류, 스넥류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알콜 음료 및 비타민 복합제등을 들 수 있다.There is no particular limitation on the kind of health food, for example, meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gum, dairy products including ice cream, various soups, beverages, tea, Drinks, alcoholic beverages, and vitamin complexes.
또한, 본 발명은 비술나무 추출물을 유효성분으로 함유는 티로시나아제, 콜라게나아제 또는 엘라스타아제의 활성 억제용 시약조성물로 제공될 수 있다.In addition, the present invention may be provided as a reagent composition for inhibiting the activity of tyrosinase, collagenase, or elastase containing the bisul tree extract as an active ingredient.
이하, 본 발명의 이해를 돕기 위하여 실시예를 들어 상세하게 설명하기로 한다. 다만 하기의 실시예는 본 발명의 내용을 예시하는 것일 뿐 본 발명의 범위가 하기 실시예에 한정되는 것은 아니다. 본 발명의 실시예는 당업계에서 평균적인 지식을 가진 자에게 본 발명을 보다 완전하게 설명하기 위해 제공되는 것이다.Hereinafter, examples will be described in detail to aid understanding of the present invention. However, the following examples are for illustrative purposes only, and the scope of the present invention is not limited to the following examples. The embodiments of the present invention are provided to more completely explain the present invention to those of ordinary skill in the art.
<참고예> 시약 및 기기<Reference Example> Reagents and equipment
Folin & Ciocalteu’s 페놀 시약, DMSO (dimethyl sulfoxide), 디에틸렌 글리콜 (diethylene glycol), 포타슘 페록소디설페이트 (potassium peroxodisulfate), 1,1-디페닐-2-폴릴 하이드라질 (1,1-diphenyl-2-polryl hydrazyl; DPPH), 탄닌산 (tannic acid), 루틴 (rutin), 4-phenylazobenzyloxycarbonyl-Pro-Leu-Gly-Pro-D-Arg, N-succinyl-(L-Ala)3-p-(nitroanilide), 콜라게나아제 (from Clostridium histolyticum), 엘라스타아제 ( from porcine pancreas), 타이로신 (tyrosine), 티로시나아제 (from mushroom)은 Sigma 사(St. Louis, MO, USA)의 제품을 사용하였으며, 그 외 일반시약들은 특급품을 사용하였다. Folin &Ciocalteu's phenol reagent, DMSO (dimethyl sulfoxide), diethylene glycol, potassium peroxodisulfate, 1,1-diphenyl-2-polylhydrazyl (1,1-diphenyl-2- polryl hydrazyl; DPPH), tannic acid, rutin, 4-phenylazobenzyloxycarbonyl-Pro-Leu-Gly-Pro-D-Arg, N -succinyl-(L-Ala) 3 -p -(nitroanilide), Collagenase (from Clostridium histolyticum) , elastase (from porcine pancreas), tyrosine, and tyrosinase (from mushroom) were manufactured by Sigma (St. Louis, MO, USA), and others. The general reagents used the special products.
<실시예 1> 비술나무 추출물 준비<Example 1> Preparation of bisul tree extract
비술나무(Ulmus pumila L.) 메탄올 추출물은 한국식물추출물은행에서 분양받아 사용하였다. 비술나무의 줄기는 강원도 영월에서 2001년 9월에 채집되었다. 플라스크에 분쇄된 시료 100 g과 1 L의 100% 메탄올을 넣고 45℃에서 1시간 동안 추출하였고, 이를 3회 반복 추출하였다. 추출액을 여과하고, 농축 및 건조시켰다. The methanol extract of Ulmus pumila L. was sold and used by the Korea Plant Extract Bank. The trunk of the secret liquor tree was collected in September 2001 in Yeongwol, Gangwon-do. 100 g of the pulverized sample and 1 L of 100% methanol were added to the flask, followed by extraction at 45° C. for 1 hour, which was repeatedly extracted three times. The extract was filtered, concentrated and dried.
비술나무 메탄올추출물의 수율은 4.5%였으며, 상기 시료를 사용하기 전에 DMSO에 용해시켰다.The yield of the methanol extract of Bismuth tree was 4.5%, and the sample was dissolved in DMSO before use.
<실시예 2> 항산화능 확인<Example 2> Confirmation of antioxidant activity
2-1. 총 폴리페놀 및 총 플라보노이드 함량 확인2-1. Determination of total polyphenol and total flavonoid content
총 폴리페놀 함량은 Folin-Denis법(Folin & Denis, 1912)으로 확인하였다. 200 μg/mL 농도로 희석한 시료 1 mL에 folin-reagent 1 mL를 가하여 3분간 실온에서 반응시킨 후 10% Na2CO3 1 mL를 혼합하고 1시간 실온에서 방치하여 725 nm에서 흡광도를 측정하였다. 검량곡선은 탄닌산을 이용하여 작성하였다.The total polyphenol content was confirmed by the Folin-Denis method (Folin & Denis, 1912). 1 mL of folin-reagent was added to 1 mL of the sample diluted to a concentration of 200 μg/mL, reacted at room temperature for 3 minutes, and then 1 mL of 10% Na2CO3 was mixed and left at room temperature for 1 hour to measure absorbance at 725 nm. The calibration curve was prepared using tannic acid.
총 플라보노이드 함량은 Davies et al.(1980)의 변법으로 확인하였다. 200 μg/mL 농도로 희석한 시료 100 μL에 디에틸렌 글리콜 1 mL를 혼합하여 5분간 실온에서 반응시킨 후 1 N NaOH 용액 100 μL를 첨가하여 37℃에서 1시간 방치하고 420 nm에서 흡광도를 측정하였으며, 검량곡선은 루틴을 사용하여 작성하였다.The total flavonoid content was confirmed by a variant of Davies et al. (1980). 1 mL of diethylene glycol was mixed with 100 μL of the sample diluted to 200 μg/mL, reacted at room temperature for 5 minutes, and then 100 μL of 1 N NaOH solution was added and left at 37°C for 1 hour, and the absorbance was measured at 420 nm. , The calibration curve was prepared using a routine.
그 결과, 도 1과 같이 비술나무 메탄올추출물의 총 폴리페놀 및 총 플라보노이드 함량은 각각 418.9 TAE(tannic acid equivalent) mg/g 및 236.1 RE(rutin equivalent) mg/g으로 나타났다.As a result, as shown in FIG. 1, the total polyphenol and total flavonoid contents of the methanol extract of Bisul tree were 418.9 TAE (tannic acid equivalent) mg/g and 236.1 RE (rutin equivalent) mg/g, respectively.
2-2. DPPH 라디칼 소거활성 확인2-2. DPPH radical scavenging activity confirmation
전자공여능은 Perez et al.(2004)의 방법으로 확인하였다. 96-웰 플레이트에 에탄올에 녹인 0.2 mM DPPH 용액 50 μL와 비술나무 메탄올추출물을 62.5, 125, 250, 500 및 1000 μg/mL 농도로 각각 100 μL씩 가하고 차광 상태에서 30분 동안 방치한 후 517 nm에서 흡광도를 측정하였다. GraphPrism 소프트웨어 Ver. 7(Graphpad Software, lnc., La Jolla, CA, USA)을 사용하여 SC50(50% scavenging concentration, 자유라디칼을 50% 소거하는 농도)을 산출하였다.The electron donating ability was confirmed by the method of Perez et al. (2004). To a 96-well plate, 50 μL of 0.2 mM DPPH solution dissolved in ethanol and 100 μL of methanol extract of Bisulnamu were added at concentrations of 62.5, 125, 250, 500, and 1000 μg/mL, respectively, and allowed to stand for 30 minutes in a light-shielding state and then 517 nm. Absorbance was measured at. GraphPrism software Ver. 7 (Graphpad Software, lnc., La Jolla, CA, USA) was used to calculate SC 50 (50% scavenging concentration, 50% free radical scavenging concentration).
그 결과, 도 2와 같이 비술나무 메탄올추출물은 농도 의존적으로 정적(+)인 용량-반응 상관관계를 보였으며, 양성대조군인 아스코르빅산과 비술나무 메탄올추출의 전자공여능은 1000 μg/mL에서 각각 97.7% 및 90.0%로 확인되었으며, 비술나무 메탄올추출물의 SC50은 282.9 μg/mL으로 확인된 반면, 아스코르빅산의 SC50은 산출되지 않았으나 62.5 μg/mL 보다 작은 것으로 확인되었다.As a result, as shown in Fig. 2, the methanol extract of Bisul tree showed a positive (+) dose-response correlation in a concentration-dependent manner, and the electron donating capacity of the positive control group, ascorbic acid and the methanol extract of Bisul tree, was at 1000 μg/mL, respectively. It was found to be 97.7% and 90.0%, and the SC 50 of the methanol extract of the bismuth was found to be 282.9 μg/mL, whereas the SC 50 of ascorbic acid was not calculated, but it was found to be smaller than 62.5 μg/mL.
<실시예 3> 효소활성 확인<Example 3> Enzyme activity confirmation
3-1. 콜라게나아제 (Collagenase) 활성 저해능 확인3-1. Confirmation of collagenase activity inhibitory ability
62.5, 125, 250, 500 및 1000 μg/mL 농도로 희석한 시료 100 μL와 4 mM의 CaCl2를 첨가한 0.1 M의 Tris-HCl buffer(pH 7.5)에 4-phenylazobenzyloxycarbonyl- Pro-Leu-Gly-Pro-D-Arg(0.3 mg/mL)를 녹인 기질액 250 μL를 혼합한 후 콜라게나아제 (0.2 mg/mL) 150 μL를 가하여 실온에서 20분간 반응시켰다. 4-phenylazobenzyloxycarbonyl-Pro-Leu-Gly- in 0.1 M Tris-HCl buffer (pH 7.5) containing 100 μL of the sample diluted to 62.5, 125, 250, 500 and 1000 μg/mL and 4 mM CaCl 2 After mixing 250 μL of a substrate solution in which Pro-D-Arg (0.3 mg/mL) was dissolved, 150 μL of collagenase (0.2 mg/mL) was added and reacted at room temperature for 20 minutes.
이후 6% 시트르산 (citric acid) 1 mL를 혼합하고 반응을 정지시키기 위하여 에틸 아세테이트 (ethyl acetate) 1.5 mL를 혼합하였다. 그 후 상층액을 취해 320 nm에서 흡광도를 측정하였다. 양성대조군으로 아스코르빅산 (ascorbic acid)을 사용하였으며, GraphPrism 소프트웨어를 사용하여 IC50(50% inhibitory concentration, collagenase 활성을 50%로 저해하는 농도)을 산출하였다.Thereafter, 1 mL of 6% citric acid was mixed, and 1.5 mL of ethyl acetate was mixed to stop the reaction. Then, the supernatant was taken and the absorbance was measured at 320 nm. Ascorbic acid was used as a positive control, and IC 50 (50% inhibitory concentration, concentration that inhibits collagenase activity to 50%) was calculated using GraphPrism software.
그 결과, 도 3과 같이 비술나무 메탄올추출물은 농도 의존적으로 정적(+)인 용량-반응 상관관계를 보였으며, 양성대조군인 아스코르빅산과 비술나무 메탄올추출의 콜라게나아제 활성저해능은 1000 μg/mL에서 각각 71.7% 및 69.4%으로 나타났다. 또한, 아스코르빅산 및 비술나무 메탄올추출물의 IC50은 각각 360.3 μg/mL 및 320.9 μg/mL로 확인되었다.As a result, as shown in FIG. 3, the methanol extract of Bisul tree showed a positive (+) dose-response correlation in a concentration-dependent manner, and the inhibitory activity of collagenase activity of the positive control, ascorbic acid and methanol extract, was 1000 μg/ In mL, they were 71.7% and 69.4%, respectively. In addition, the IC 50 of the methanol extract of ascorbic acid and bisulnamu was found to be 360.3 μg/mL and 320.9 μg/mL, respectively.
3-2. 엘라스타아제 (Elastase) 활성 저해능 확인3-2. Confirmation of inhibitory ability of elastase activity
62.5, 125, 250, 500 및 1000 μg/mL 농도로 희석한 시료 15 μL에 100 mM의 Tris-HCl buffer(pH 8)에 녹인 돼지 췌장 엘라스타아제 (porcine pancrease elastase) 0.2 unit 5 μL와 N-succcinyl-(L-Ala)3-p-nitroa-nilide(0.5 mg/mL)를 녹인 기질액 20 μL를 첨가하여 37℃에서 10분간 반응시켰다. 5 μL of 0.2 unit of porcine pancrease elastase dissolved in 15 μL of samples diluted to 62.5, 125, 250, 500 and 1000 μg/mL in 100 mM Tris-HCl buffer (pH 8) and N- 20 μL of a substrate solution in which succcinyl-(L-Ala)3-p-nitroa-nilide (0.5 mg/mL) was dissolved was added and reacted at 37° C. for 10 minutes.
그 후 얼음에서 5분간 냉각 시킨 후 410 nm에서 흡광도를 측정하였다. 양성대조군으로 아스코르빅산을 사용하였으며, GraphPrism 소프트웨어를 사용하여 IC50(50% inhibitory concentration, elastase 활성을 50%로 저해하는 농도)을 산출하였다.After cooling for 5 minutes on ice, the absorbance was measured at 410 nm. Ascorbic acid was used as a positive control, and IC 50 (50% inhibitory concentration, concentration inhibiting elastase activity to 50%) was calculated using GraphPrism software.
그 결과, 도 4와 같이 비술나무 메탄올추출물은 농도 의존적으로 정적(+)인 용량-반응 상관관계를 보였으며, 양성대조군인 아스코르빅산과 비술나무 메탄올추출의 엘라스타아제 활성저해능은 1000 μg/mL에서 각각 45.6% 및 61.2%으로 나타났으며, 비술나무 메탄올추출물의 IC50은 731.1 μg/mL로 확인되었다.As a result, as shown in FIG. 4, the methanol extract of Bisul tree showed a positive (+) dose-response correlation in a concentration-dependent manner, and the inhibitory activity of elastase activity of the methanol extract of ascorbic acid and Bisul tree, which was a positive control, was 1000 μg/ It was found to be 45.6% and 61.2% in mL, respectively, and the IC 50 of the methanol extract of Bisulwood was found to be 731.1 μg/mL.
반면 아스코르빅산의 IC50은 산출되지 않았으나 1000 μg/mL 보다 큰 것으로 확인되었다.On the other hand, the IC 50 of ascorbic acid was not calculated, but it was found to be greater than 1000 μg/mL.
3-3. 티로시나아제 (Mushroom tyrosinase) 활성 저해능 확인3-3. Confirmation of tyrosinase (Mushroom tyrosinase) activity inhibition
62.5, 125, 250, 500 및 1000 μg/mL 농도로 희석한 시료 5 μL에 sodium phosphate buffer(pH 6.8) 50 μL, 0.03% 티로신 50 μL, 버섯 티로시나아제 (mushroom tyrosinase) 10 μL를 넣은 후 37℃에서 10분간 반응시킨 후 얼음에서 5분간 냉각 시키고 475 nm에서 흡광도를 측정하였다. 양성대조군으로 알부틴 (arbutin)을 사용하였으며, GraphPrism 소프트웨어를 사용하여 IC50(50% inhibitory concentration, tyrosinase 활성을 50%로 저해하는 농도)을 산출하였다.Add 50 μL of sodium phosphate buffer (pH 6.8), 50 μL of 0.03% tyrosine, and 10 μL of mushroom tyrosinase to 5 μL of the sample diluted to 62.5, 125, 250, 500 and 1000 μg/mL. After reacting at °C for 10 minutes, it was cooled on ice for 5 minutes, and absorbance was measured at 475 nm. Arbutin was used as a positive control, and IC 50 (50% inhibitory concentration, concentration that inhibits tyrosinase activity to 50%) was calculated using GraphPrism software.
그 결과, 도 5와 같이 비술나무 메탄올추출물은 농도 의존적으로 정적(+)인 용량-반응 상관관계를 보였으며, 양성대조군인 알부틴과 비술나무 메탄올추출물과의 버섯 티로시나아제 활성저해능은 1000 μg/mL 농도에서 각각 70.8% 및 65.9%로 나타났으며, 알부틴과 비술나무 메탄올추출물의 IC50은 각각 240.7 μg/mL 및 258.6 μg/mL로 확인되었다.As a result, as shown in FIG. 5, the methanol extract of Bisul tree showed a positive (+) dose-response correlation in a concentration-dependent manner, and the inhibitory activity of mushroom tyrosinase activity between the positive control arbutin and the methanol extract of Bisul tree was 1000 μg/ The concentrations in mL were 70.8% and 65.9%, respectively, and the IC 50s of the methanol extract of arbutin and bisulnamu were found to be 240.7 μg/mL and 258.6 μg/mL, respectively.
이상으로 본 발명 내용의 특정한 부분을 상세히 기술하였는 바, 당업계의 통상의 지식을 가진 자에게 있어서, 이러한 구체적 기술은 단지 바람직한 실시양태일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 명백할 것이다. 따라서 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의하여 정의된다고 할 것이다.As described above, specific parts of the present invention have been described in detail, and for those of ordinary skill in the art, it is obvious that these specific techniques are only preferred embodiments, and the scope of the present invention is not limited thereby. something to do. Therefore, it will be said that the practical scope of the present invention is defined by the appended claims and their equivalents.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190074209A KR20200145340A (en) | 2019-06-21 | 2019-06-21 | Composition for skin whitening comprising ulmus pumila extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190074209A KR20200145340A (en) | 2019-06-21 | 2019-06-21 | Composition for skin whitening comprising ulmus pumila extract |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20200145340A true KR20200145340A (en) | 2020-12-30 |
Family
ID=74088808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190074209A KR20200145340A (en) | 2019-06-21 | 2019-06-21 | Composition for skin whitening comprising ulmus pumila extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20200145340A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140104142A (en) | 2013-02-20 | 2014-08-28 | 한울환경연구원(주) | A Composition of Platanus orientalis L extract for anti whitening, wrinkle, aging |
-
2019
- 2019-06-21 KR KR1020190074209A patent/KR20200145340A/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140104142A (en) | 2013-02-20 | 2014-08-28 | 한울환경연구원(주) | A Composition of Platanus orientalis L extract for anti whitening, wrinkle, aging |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7014844B2 (en) | Lightening compositions and methods of use | |
KR101125392B1 (en) | Cosmetic Composition comprising Extracts of Aronia mandschurica | |
KR102193209B1 (en) | Cosmetic composition for skin whitening comprising extract of Phragmites Communis | |
KR102253376B1 (en) | Composition for improving winkle or skin whitening comprising atriplex gmelinii extract or paederia scandens extract | |
KR100728813B1 (en) | Cosmetic composition containing extract of cirsium setidens | |
KR20220166356A (en) | Extract of Moringa peregrina seed cake, process for its preparation and its use in cosmetic or nutricosmetic compositions | |
KR101971243B1 (en) | Composition for Whitening Skin Comprising 4'-O-Methylalpinum Isoflavone or Pharmaceutically Acceptable Salt Thereof | |
KR20200145340A (en) | Composition for skin whitening comprising ulmus pumila extract | |
KR20090097550A (en) | Cosmetic composition containing schizandrin and extracts | |
KR102471009B1 (en) | Cosmetic composition containing Albiggia kalkora extract for skin whitening and improving wrinkles | |
KR102236021B1 (en) | Composition for skin whitening or improving winkle comprising hemiptelea davidii extract | |
KR20180128774A (en) | A composition for antioxidating, whitening and improving wrinkle comprising flower extract | |
KR102246588B1 (en) | Composition for skin whitening or improving winkle comprising rhamnus davurica extract | |
KR20210004155A (en) | Composition for improving winkle or skin whitening comprising coreopsis lanceolate l. extract | |
KR102236022B1 (en) | Composition for skin whitening or improving winkle comprising sonchus brachyotus extract | |
KR100566857B1 (en) | Cosmetic Composition of Lifting and Whitening Ingredient Containing Saponin extracted from Rhynchosia Molubilis | |
KR20130052288A (en) | Cosmetic composition comprising the hot spring water extract of nelumbo nucifera gaertner as active ingredient | |
KR101987425B1 (en) | A cosmetic composition comprising salix gracilistyla extract | |
KR102236023B1 (en) | Composition for anti-wrinkle or skin whitening comprising Daphne kiusiana extract | |
KR20220004119A (en) | Method for inhibiting PAR2 activation and composition therefor | |
KR100508528B1 (en) | method for manufacturng the Skin Cosmetics using horse bean and Golden larch extract | |
KR100552269B1 (en) | A cosmetic composition containing extract of Campsis grandiflora and/or Torreya nucifera seed | |
KR102214557B1 (en) | Cosmetic composition comprising dystaenia takeshimana extract | |
KR102405596B1 (en) | cosmetic composition comprising Milyang20 sorghum extract | |
JP2012036148A (en) | Sustainable skin whitening agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E601 | Decision to refuse application |